Galapagos NV
Utility Patents

Last updated:

List of all Galapagos NV patents 26 in total

Status Patent
Grant
Utility: Prodrug modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Compounds and pharmaceutical compositions thereof for the treatment of diseases External link
Filling date: 8 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Pyrrolopyrimidine and pyrrolopyridine derivatives External link
Filling date: 8 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Compound useful for the treatment of degenerative and inflammatory diseases External link
Filling date: 8 Sep 2025 Issue date: 11 May 2021
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis External link
Filling date: 8 Sep 2025 Issue date: 9 Mar 2021
Grant
Utility: Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis External link
Filling date: 8 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use External link
Filling date: 8 Sep 2025 Issue date: 12 May 2020
Grant
Utility: Heteroaryl substituted pyridines and methods of use External link
Filling date: 8 Sep 2025 Issue date: 31 Mar 2020
Grant
Utility: Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis External link
Filling date: 8 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors External link
Filling date: 8 Sep 2025 Issue date: 17 Dec 2019
Grant
Utility: Pharmaceutical compositions for the treatment of inflammatory disorders External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2019
Grant
Utility: 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis External link
Filling date: 8 Sep 2025 Issue date: 26 Nov 2019
Grant
Utility: Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2019
Grant
Utility: Substituted pyrrolidines and methods of use External link
Filling date: 8 Sep 2025 Issue date: 3 Sep 2019
Grant
Utility: Methods for the treatment of cardiovascular disorders External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2019

Showing 1 to 26 of 26 patents.